Eric Wong
Papers
1
Total Citations
35
H-Index
1
About
Eric Wong has made significant contributions to the field of radiation oncology, with a particular focus on stereotactic radiotherapy for skull base tumors. His key research areas include hypofractionated stereotactic radiotherapy (HSRT) and its clinical applications for benign intracranial lesions. Wong's most cited work, "Clinical outcome after Hypofractionated Stereotactic Radiotherapy (HSRT) for benign skull base tumors" (2011, 35 citations), addresses a critical challenge in neurosurgery: balancing effective tumor control with minimizing treatment morbidity. He demonstrated that HSRT offers a viable, less invasive alternative to surgical resection for benign skull base tumors, providing precise radiation delivery that spares surrounding healthy tissue. This work has helped establish HSRT as a standard option for patients where surgical risks outweigh benefits, influencing clinical protocols and improving patient outcomes. Wong's research underscores the importance of optimizing dose regimes to achieve tumor growth control while reducing side effects, making him a notable figure in advancing non-surgical treatments for complex cranial tumors. His contributions continue to guide radiation oncologists and neurosurgeons in personalized treatment planning.
Research Focus
Key Achievements
Top Papers
- 1